衰老定义了一种独特的肌成纤维细胞亚群,该亚群协调胰腺癌中的免疫抑制
该研究在小鼠和人胰腺导管腺癌(PDAC)中鉴定出一个衰老的肌成纤维细胞CAF亚群(SenCAF),其定位于肿瘤导管附近并随PDAC进展而积累。在小鼠模型中清除衰老基质细胞可减轻巨噬细胞介导的免疫抑制、延缓肿瘤进展并提高化疗反应性。作者认为靶向CAF衰老的联合治疗可能增加肿瘤对化疗或免疫治疗的脆弱性。
要点
- 在PDAC中鉴定出衰老肌成纤维细胞CAF亚群SenCAF,定位于肿瘤导管附近并随进展积累。
- 小鼠模型中清除衰老基质细胞可减轻巨噬细胞免疫抑制、延缓肿瘤进展。
- 清除衰老基质细胞可提高PDAC对化疗的反应性。
核心结论
- SenCAF促进PDAC进展和免疫细胞功能障碍。
- 作者认为靶向CAF衰老的联合治疗可能增加肿瘤对化疗或免疫治疗的脆弱性。
研究设计与样本
- 研究在小鼠和人PDAC中鉴定衰老肌成纤维细胞CAF亚群。
- 使用LSL-KRASG12D;p53flox;p48-CRE;INK-ATTAC(KPPC-IA)小鼠自发性PDAC模型,该模型可诱导性清除衰老细胞。
- 在遗传学和药理学PDAC模型中清除衰老基质细胞以评估其影响。
主要发现
- SenCAF是肌成纤维细胞CAF中表型独特的亚群,定位于肿瘤导管附近并随PDAC进展而积累。
- 在遗传学和药理学PDAC模型中清除衰老基质细胞可减轻巨噬细胞的免疫抑制。
- 在遗传学和药理学PDAC模型中清除衰老基质细胞可延缓肿瘤进展。
- 在遗传学和药理学PDAC模型中清除衰老基质细胞可增加对化疗的反应性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pancreatic ductal adenocarcinoma (PDAC) therapeutic resistance is largely attributed to a unique tumor microenvironment embedded with an abundance of cancer-associated fibroblasts (CAF). Distinct CAF populations were recently identified, but the phenotypic drivers and specific impact of CAF heterogeneity remain unclear. In this study, we identify a subpopulation of senescent myofibroblastic CAFs (SenCAF) in mouse and human PDAC. These SenCAFs are a phenotypically distinct subset of myofibroblastic CAFs that localize near tumor ducts and accumulate with PDAC progression. To assess the impact of endogenous SenCAFs in PDAC, we used an LSL-KRASG12D;p53flox;p48-CRE;INK-ATTAC (KPPC-IA) mouse model of spontaneous PDAC with inducible senescent cell depletion. Depletion of senescent stromal cells in genetic and pharmacologic PDAC models relieved immune suppression by macrophages, delayed tumor progression, and increased responsiveness to chemotherapy. Collectively, our findings demonstrate that SenCAFs promote PDAC progression and immune cell dysfunction. Significance: CAF heterogeneity in PDAC remains poorly understood. In this study, we identify a novel subpopulation of senescent CAFs that promotes PDAC progression and immunosuppression. Targeting CAF senescence in combination therapies could increase tumor vulnerability to chemo or immunotherapy. See related article by Ye et al., p. 1302.
引用
- Belle JI, Sen D, Baer JM, et al. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. Cancer Discov. 2024. PMID: 38683144. doi:10.1158/2159-8290.CD-23-0428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。